NDC 0067-2035

Excedrin Migraine Geltabs

Acetaminophen, Asprin, Caffeine

Excedrin Migraine Geltabs is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Acetaminophen; Aspirin; Caffeine.

• Product ID: 0067-2035_edbb64b9-f8ba-48db-8a36-d5837114f822
• NDC: 0067-2035
• Product Type: Human Otc Drug
• Proprietary Name: Excedrin Migraine Geltabs
• Generic Name: Acetaminophen, Asprin, Caffeine
• Dosage Form: Tablet, Coated
• Route of Administration: ORAL
• Marketing Start Date: 2011-09-13
• Marketing Category: NDA / NDA
• Application Number: NDA020802
• Labeler Name: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
• Substance Name: ACETAMINOPHEN; ASPIRIN; CAFFEINE
• Active Ingredient Strength: 250 mg/1; mg/1; mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0067-2035-20

1 BOTTLE in 1 CARTON (0067-2035-20) > 20 TABLET, COATED in 1 BOTTLE

• Marketing Start Date: 2011-09-13
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0067-2035-50 [00067203550]

Excedrin Migraine Geltabs TABLET, COATED

• Marketing Category: NDA
• Application Number: NDA020802
• Product Type: HUMAN OTC DRUG
• Billing Unit: EA
• Marketing Start Date: 2011-09-13
• Marketing End Date: 2014-12-31

NDC 0067-2035-80 [00067203580]

Excedrin Migraine Geltabs TABLET, COATED

• Marketing Category: NDA
• Application Number: NDA020802
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2011-09-13

NDC 0067-2035-24 [00067203524]

Excedrin Migraine Geltabs TABLET, COATED

• Marketing Category: NDA
• Application Number: NDA020802
• Product Type: HUMAN OTC DRUG
• Billing Unit: EA
• Marketing Start Date: 2011-09-13
• Marketing End Date: 2014-12-31

NDC 0067-2035-16 [00067203516]

Excedrin Migraine Geltabs TABLET, COATED

• Marketing Category: NDA
• Application Number: NDA020802
• Product Type: HUMAN OTC DRUG
• Billing Unit: EA
• Marketing Start Date: 2011-09-13
• Marketing End Date: 2014-12-31

NDC 0067-2035-91 [00067203591]

Excedrin Migraine Geltabs TABLET, COATED

• Marketing Category: NDA
• Application Number: NDA020802
• Product Type: HUMAN OTC DRUG
• Billing Unit: EA
• Marketing Start Date: 2011-09-13
• Marketing End Date: 2014-12-31

NDC 0067-2035-20 [00067203520]

Excedrin Migraine Geltabs TABLET, COATED

• Marketing Category: NDA
• Application Number: NDA020802
• Product Type: HUMAN OTC DRUG
• Billing Unit: EA
• Marketing Start Date: 2011-09-13

Drug Details

Active Ingredients

Ingredient	Strength
ACETAMINOPHEN	250 mg/1

OpenFDA Data

• SPL SET ID: cc2f4a6f-2a27-4a60-b5ef-ae0bb0988ff8
• Manufacturer:
  • GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
• UNII:
  • 362O9ITL9D
  • R16CO5Y76E
  • 3G6A5W338E
• RxNorm Concept Unique ID - RxCUI:
  • 308297
  • 209468
• Pharm Class PE:
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
• PHarm Class EPC:
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
• NUI Code:
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722

NDC Crossover Matching brand name "Excedrin Migraine Geltabs" or generic name "Acetaminophen, Asprin, Caffeine"

NDC	Brand Name	Generic Name
0067-2021	Excedrin	Acetaminophen, Asprin, Caffeine
0067-2035	Excedrin	Acetaminophen, Asprin, Caffeine